Skip to content
10-Q

Quarterly Report

ProLung, Inc.

0001493152-21-028217

← back to feed
Filed
Nov 12, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Nov 12, 2021 4.12M sh
Cash And Equivalents Q3 2021 · Sep 30, 2021 $1.15M
Cash And Equivalents Q3 2021 · Dec 31, 2020 $185.13K
Current Liabilities Q3 2021 · Sep 30, 2021 $12.11M
Current Liabilities Q3 2021 · Dec 31, 2020 $1.73M
Total Liabilities Q3 2021 · Sep 30, 2021 $12.11M
Total Liabilities Q3 2021 · Dec 31, 2020 $9.23M
Current Assets Q3 2021 · Sep 30, 2021 $1.15M
Current Assets Q3 2021 · Dec 31, 2020 $190.55K
Total Assets Q3 2021 · Sep 30, 2021 $1.3M
Total Assets Q3 2021 · Dec 31, 2020 $389.2K
Short Term Debt Q3 2021 · Dec 31, 2020 $105K
Capex Q3 2021 · Sep 30, 2020 $3.59K
Operating Cash Flow Q3 2021 · Sep 30, 2020 −$1.6M
Stockholders Equity Q3 2021 · Sep 30, 2020 −$8.38M
Stockholders Equity Q3 2021 · Jun 30, 2020 −$7.76M
Stockholders Equity Q3 2021 · Mar 31, 2020 −$7.18M
Stockholders Equity Q3 2021 · Dec 31, 2019 −$6.7M
Sga Expense Q3 2021 · Sep 30, 2020 $291.18K
Sga Expense Q3 2021 · Sep 30, 2020 $1.1M
Rd Expense Q3 2021 · Sep 30, 2020 $165.89K
Rd Expense Q3 2021 · Sep 30, 2020 $555.83K
Net Income Q3 2021 · Sep 30, 2020 −$665.74K
Net Income Q3 2021 · Sep 30, 2020 −$2.19M
Net Income Q3 2021 · Jun 30, 2020 −$806.74K
Net Income Q3 2021 · Mar 31, 2020 −$712.88K
Operating Income Q3 2021 · Sep 30, 2020 −$457.07K
Operating Income Q3 2021 · Sep 30, 2020 −$1.66M